Ursapharm Arzneimittel is a finished-dose manufacturer based in Germany. It appears in 61 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, EDE (AE) and NPRA (MY). Its GMP standing is certified by ZLG (DE), ANVISA (Brazil) and EMA, among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 31 October 2024 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Sarrbrucken, United Arab Emirates | Not on file |
| SAARBRÜCKEN, Germany | Not on file |
| Germany, Germany | 3004978466 |
| Saarland, Germany | Not on file |
| Saarbruecken, Germany | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | 31 | 1 |
| EDE (AE) | 12 | None |
| NPRA (MY) | 8 | None |
| ARCSA (EC) | 6 | None |
| UZPHARM (UZ) | 2 | None |
| SFDA (Saudi Arabia) | 1 | None |
| ZLG (DE) | None | 6 |
| ANVISA (Brazil) | None | 1 |
| US FDA | None | 1 |
Choose your molecules and target markets. Ursapharm Arzneimittel comes back tiered against every other supplier able to file there.
Start for free